IBDEI0JB ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,8689,1,3,0)
;;=3^Bone Mets
;;^UTILITY(U,$J,358.3,8689,1,4,0)
;;=4^C79.51
;;^UTILITY(U,$J,358.3,8689,2)
;;=^5001350
;;^UTILITY(U,$J,358.3,8690,0)
;;=C80.1^^39^401^171
;;^UTILITY(U,$J,358.3,8690,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8690,1,3,0)
;;=3^Malig Neop,Primary,Unspec Site
;;^UTILITY(U,$J,358.3,8690,1,4,0)
;;=4^C80.1
;;^UTILITY(U,$J,358.3,8690,2)
;;=^5001389
;;^UTILITY(U,$J,358.3,8691,0)
;;=C80.0^^39^401^172
;;^UTILITY(U,$J,358.3,8691,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8691,1,3,0)
;;=3^Malig Neop,Unspec Primary or Secondary
;;^UTILITY(U,$J,358.3,8691,1,4,0)
;;=4^C80.0
;;^UTILITY(U,$J,358.3,8691,2)
;;=^5001388
;;^UTILITY(U,$J,358.3,8692,0)
;;=E28.39^^39^401^96
;;^UTILITY(U,$J,358.3,8692,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8692,1,3,0)
;;=3^Hypogonadism,Ovarian
;;^UTILITY(U,$J,358.3,8692,1,4,0)
;;=4^E28.39
;;^UTILITY(U,$J,358.3,8692,2)
;;=^5002752
;;^UTILITY(U,$J,358.3,8693,0)
;;=E29.1^^39^401^97
;;^UTILITY(U,$J,358.3,8693,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8693,1,3,0)
;;=3^Hypogonadism,Testicular
;;^UTILITY(U,$J,358.3,8693,1,4,0)
;;=4^E29.1
;;^UTILITY(U,$J,358.3,8693,2)
;;=^5002754
;;^UTILITY(U,$J,358.3,8694,0)
;;=C96.20^^39^401^111
;;^UTILITY(U,$J,358.3,8694,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8694,1,3,0)
;;=3^Malig Mast Cell Neoplasm,Unspec
;;^UTILITY(U,$J,358.3,8694,1,4,0)
;;=4^C96.20
;;^UTILITY(U,$J,358.3,8694,2)
;;=^5151293
;;^UTILITY(U,$J,358.3,8695,0)
;;=C96.22^^39^401^173
;;^UTILITY(U,$J,358.3,8695,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8695,1,3,0)
;;=3^Mast Cell Sarcoma
;;^UTILITY(U,$J,358.3,8695,1,4,0)
;;=4^C96.22
;;^UTILITY(U,$J,358.3,8695,2)
;;=^5151295
;;^UTILITY(U,$J,358.3,8696,0)
;;=D64.9^^39^401^26
;;^UTILITY(U,$J,358.3,8696,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8696,1,3,0)
;;=3^Anemia,Unspec
;;^UTILITY(U,$J,358.3,8696,1,4,0)
;;=4^D64.9
;;^UTILITY(U,$J,358.3,8696,2)
;;=^5002351
;;^UTILITY(U,$J,358.3,8697,0)
;;=D59.10^^39^401^32
;;^UTILITY(U,$J,358.3,8697,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8697,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Unspec
;;^UTILITY(U,$J,358.3,8697,1,4,0)
;;=4^D59.10
;;^UTILITY(U,$J,358.3,8697,2)
;;=^5159101
;;^UTILITY(U,$J,358.3,8698,0)
;;=D59.11^^39^401^33
;;^UTILITY(U,$J,358.3,8698,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8698,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Warm
;;^UTILITY(U,$J,358.3,8698,1,4,0)
;;=4^D59.11
;;^UTILITY(U,$J,358.3,8698,2)
;;=^5159102
;;^UTILITY(U,$J,358.3,8699,0)
;;=D59.12^^39^401^29
;;^UTILITY(U,$J,358.3,8699,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8699,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Cold
;;^UTILITY(U,$J,358.3,8699,1,4,0)
;;=4^D59.12
;;^UTILITY(U,$J,358.3,8699,2)
;;=^5159103
;;^UTILITY(U,$J,358.3,8700,0)
;;=D59.13^^39^401^30
;;^UTILITY(U,$J,358.3,8700,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8700,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Mixed Type
;;^UTILITY(U,$J,358.3,8700,1,4,0)
;;=4^D59.13
;;^UTILITY(U,$J,358.3,8700,2)
;;=^5159104
;;^UTILITY(U,$J,358.3,8701,0)
;;=D59.19^^39^401^31
;;^UTILITY(U,$J,358.3,8701,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,8701,1,3,0)
;;=3^Autoimmune Hemolytic Anemia,Other
;;^UTILITY(U,$J,358.3,8701,1,4,0)
;;=4^D59.19
;;^UTILITY(U,$J,358.3,8701,2)
;;=^5159105
;;^UTILITY(U,$J,358.3,8702,0)
;;=D57.20^^39^401^201
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0JB 3774 printed Sep 23, 2025@19:25:47 Page 2
IBDEI0JB ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,8689,1,3,0)
+2 ;;=3^Bone Mets
+3 ;;^UTILITY(U,$J,358.3,8689,1,4,0)
+4 ;;=4^C79.51
+5 ;;^UTILITY(U,$J,358.3,8689,2)
+6 ;;=^5001350
+7 ;;^UTILITY(U,$J,358.3,8690,0)
+8 ;;=C80.1^^39^401^171
+9 ;;^UTILITY(U,$J,358.3,8690,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,8690,1,3,0)
+12 ;;=3^Malig Neop,Primary,Unspec Site
+13 ;;^UTILITY(U,$J,358.3,8690,1,4,0)
+14 ;;=4^C80.1
+15 ;;^UTILITY(U,$J,358.3,8690,2)
+16 ;;=^5001389
+17 ;;^UTILITY(U,$J,358.3,8691,0)
+18 ;;=C80.0^^39^401^172
+19 ;;^UTILITY(U,$J,358.3,8691,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,8691,1,3,0)
+22 ;;=3^Malig Neop,Unspec Primary or Secondary
+23 ;;^UTILITY(U,$J,358.3,8691,1,4,0)
+24 ;;=4^C80.0
+25 ;;^UTILITY(U,$J,358.3,8691,2)
+26 ;;=^5001388
+27 ;;^UTILITY(U,$J,358.3,8692,0)
+28 ;;=E28.39^^39^401^96
+29 ;;^UTILITY(U,$J,358.3,8692,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,8692,1,3,0)
+32 ;;=3^Hypogonadism,Ovarian
+33 ;;^UTILITY(U,$J,358.3,8692,1,4,0)
+34 ;;=4^E28.39
+35 ;;^UTILITY(U,$J,358.3,8692,2)
+36 ;;=^5002752
+37 ;;^UTILITY(U,$J,358.3,8693,0)
+38 ;;=E29.1^^39^401^97
+39 ;;^UTILITY(U,$J,358.3,8693,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,8693,1,3,0)
+42 ;;=3^Hypogonadism,Testicular
+43 ;;^UTILITY(U,$J,358.3,8693,1,4,0)
+44 ;;=4^E29.1
+45 ;;^UTILITY(U,$J,358.3,8693,2)
+46 ;;=^5002754
+47 ;;^UTILITY(U,$J,358.3,8694,0)
+48 ;;=C96.20^^39^401^111
+49 ;;^UTILITY(U,$J,358.3,8694,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,8694,1,3,0)
+52 ;;=3^Malig Mast Cell Neoplasm,Unspec
+53 ;;^UTILITY(U,$J,358.3,8694,1,4,0)
+54 ;;=4^C96.20
+55 ;;^UTILITY(U,$J,358.3,8694,2)
+56 ;;=^5151293
+57 ;;^UTILITY(U,$J,358.3,8695,0)
+58 ;;=C96.22^^39^401^173
+59 ;;^UTILITY(U,$J,358.3,8695,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,8695,1,3,0)
+62 ;;=3^Mast Cell Sarcoma
+63 ;;^UTILITY(U,$J,358.3,8695,1,4,0)
+64 ;;=4^C96.22
+65 ;;^UTILITY(U,$J,358.3,8695,2)
+66 ;;=^5151295
+67 ;;^UTILITY(U,$J,358.3,8696,0)
+68 ;;=D64.9^^39^401^26
+69 ;;^UTILITY(U,$J,358.3,8696,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,8696,1,3,0)
+72 ;;=3^Anemia,Unspec
+73 ;;^UTILITY(U,$J,358.3,8696,1,4,0)
+74 ;;=4^D64.9
+75 ;;^UTILITY(U,$J,358.3,8696,2)
+76 ;;=^5002351
+77 ;;^UTILITY(U,$J,358.3,8697,0)
+78 ;;=D59.10^^39^401^32
+79 ;;^UTILITY(U,$J,358.3,8697,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,8697,1,3,0)
+82 ;;=3^Autoimmune Hemolytic Anemia,Unspec
+83 ;;^UTILITY(U,$J,358.3,8697,1,4,0)
+84 ;;=4^D59.10
+85 ;;^UTILITY(U,$J,358.3,8697,2)
+86 ;;=^5159101
+87 ;;^UTILITY(U,$J,358.3,8698,0)
+88 ;;=D59.11^^39^401^33
+89 ;;^UTILITY(U,$J,358.3,8698,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,8698,1,3,0)
+92 ;;=3^Autoimmune Hemolytic Anemia,Warm
+93 ;;^UTILITY(U,$J,358.3,8698,1,4,0)
+94 ;;=4^D59.11
+95 ;;^UTILITY(U,$J,358.3,8698,2)
+96 ;;=^5159102
+97 ;;^UTILITY(U,$J,358.3,8699,0)
+98 ;;=D59.12^^39^401^29
+99 ;;^UTILITY(U,$J,358.3,8699,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,8699,1,3,0)
+102 ;;=3^Autoimmune Hemolytic Anemia,Cold
+103 ;;^UTILITY(U,$J,358.3,8699,1,4,0)
+104 ;;=4^D59.12
+105 ;;^UTILITY(U,$J,358.3,8699,2)
+106 ;;=^5159103
+107 ;;^UTILITY(U,$J,358.3,8700,0)
+108 ;;=D59.13^^39^401^30
+109 ;;^UTILITY(U,$J,358.3,8700,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,8700,1,3,0)
+112 ;;=3^Autoimmune Hemolytic Anemia,Mixed Type
+113 ;;^UTILITY(U,$J,358.3,8700,1,4,0)
+114 ;;=4^D59.13
+115 ;;^UTILITY(U,$J,358.3,8700,2)
+116 ;;=^5159104
+117 ;;^UTILITY(U,$J,358.3,8701,0)
+118 ;;=D59.19^^39^401^31
+119 ;;^UTILITY(U,$J,358.3,8701,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,8701,1,3,0)
+122 ;;=3^Autoimmune Hemolytic Anemia,Other
+123 ;;^UTILITY(U,$J,358.3,8701,1,4,0)
+124 ;;=4^D59.19
+125 ;;^UTILITY(U,$J,358.3,8701,2)
+126 ;;=^5159105
+127 ;;^UTILITY(U,$J,358.3,8702,0)
+128 ;;=D57.20^^39^401^201
